Study co-authors from Duke University stand in the lab together. (IMAGE)

Duke University

Study co-authors from Duke University stand in the lab together.

Caption

From left, Duke University School of Medicine researchers Susan K. Murphy; Andrew Berchuck, MD; Yasaman Setayeshpour, PhD, and Jen-Tsan Ashley Chi, PhD, are studying how a common class of cholesterol drugs, called fibrates, can strip away a key defense used by ovarian cancer cells, making them more vulnerable to treatment.

Credit

Photo credit: Duke University School of Medicine/Mark Dolejs

Usage Restrictions

Noncommercial use only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.